bpc 157 and tp500 Multifunctionality Possible Medical Application of the Peptide—Literature and Patent Review BPC-157 + TB-500 Peptides |

Often, complementary strategies (eg, statin to lower cholesterol production plus a bile acid sequestrant to lower cholesterol absorption) are combined to meet cholesterol-lowering goals

However, nearly 1 in 4 adults are estimated to be deficientespecially during the winter months or due to limited sun exposure, dietary gaps, or certain health conditions

Nov 2015;104(5):1074-81

FDA-approved for treating B12 deficiency

Batch: GF112025092 Key analytical results include: BPC-157 Assay Content: 15.51 mg BPC-157 Identification Retention Time: 0.997 TB-500 (Thymosin Beta-4) Assay Content: 15.41 mg TB-500 Identification Retention Time: 0.989 Bacterial Endotoxins: below 0.001 EU per mg Total Aerobic Microbial Count: not detected Total Yeast and Mold Count: not detected Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium

BPC-157 is not FDA-approved for medical use and is classified as a research peptide